Mechanism of Protection by Soluble Epoxide Hydrolase Inhibition in Type 2 Diabetic Stroke

Inhibition of soluble epoxide hydrolase (sEH) is a potential target of therapy for ischemic injury. sEH metabolizes neuroprotective epoxyeicosatrienoic acids (EETs). We recently demonstrated that sEH inhibition reduces infarct size after middle cerebral artery occlusion (MCAO) in type 1 diabetic mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuloaga, Kristen L., Krasnow, Stephanie M., Zhu, Xinxia, Zhang, Wenri, Jouihan, Sari A., Shangraw, Robert E., Alkayed, Nabil J., Marks, Daniel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019567/
https://www.ncbi.nlm.nih.gov/pubmed/24824753
http://dx.doi.org/10.1371/journal.pone.0097529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019567/
https://www.ncbi.nlm.nih.gov/pubmed/24824753
http://dx.doi.org/10.1371/journal.pone.0097529

Ejemplares similares